16 Nov 2021 Research
John Goldman Fellowships for 2022 open in December
Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2022, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman Fellowships.
Applications for the annual fellowship programme open on 1st December 2021 to scientists and clinician-scientists working in UK universities, research institutions or hospitals. There is no age limit, although the fellowship programme is designed to provide funding at a critical point in a researcher’s career – the transition to becoming an independent researcher.
We have now increased the maximum award available to £150,000, to span a minimum 18-month and maximum 2-year period.
The John Goldman Fellowships were created in honour of Professor John Goldman (1938 – 2013), a renowned haematologist and pioneer in the treatment of leukaemia.
The awards are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice.
Successful applicants will show that they are the potential scientific/clinical leaders of the future. Their proposed research project must be novel with the capacity to make advances in our knowledge of leukaemia and related diseases and the development of new and kinder treatments.
Find out more about the 2021 John Goldman Fellows and their research projects:
Dr Daniel Coleman- AML: Developing kinder treatments by targeting mutated RAS
Dr Pramila Krishnamurthy – Understanding how donor lymphocyte infusion can prevent leukaemia patients from relapsing after a stem cell transplant
Dr Samanta Mariani – Investigating the role of macrophages in infant leukaemia
Dr William Grey (pictured above) – Could targeting the repertoire of proteins in AML lead to improved survival for the most at risk patients?
Dr Giulia Orlando (pictured right) – The role of RAS in Juvenile Myelomonocytic Leukaemia-finding new therapies?
Applications for the 2022 fellowships close on 31st January 2022. Find out more about the application process.
Related posts
12 December 2022
Widespread coverage of new leukaemia therapy shows promise in first trial patient
As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…
15 June 2018
Nick Boles’ Ambulatory Care Unit opening speech
An edited extract of the speech Nick Boles MP made at the official opening of the Leukaemia UK Ambulatory Care Unit.
26 January 2026
The latest developments and our response
The government is set to launch the National Cancer Plan for England on 4th February. We are urging policymakers to ensure it delivers meaningful change specifically for people with leukaemia….
1 August 2022
Pedalling pair’s crazy peaks challenge to stop leukaemia cutting short the lives of beloved mums
Leukaemia UK supporter, Alistair, who lost is mum to leukaemia less than a year ago, is setting out on an extreme fundraising challenge. Alistair, who is from Lincoln, and his…